Zanzalintinib in Men With Aggressive Variant Prostate Cancer

Clinical trial NCT07218666 · RECRUITING

Trial details

NCT number: NCT07218666
Sponsor: Deepak Kilari
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Aggressive Variant Prostate Carcinoma

Start date: 2026-07-01
Primary completion: 2028-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.